BRITTANY KORNFEHL: Open Payments
NPI 1619471117 · FOND DU LAC, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 17 payments from 8 companies in 2025. Trend: 2023 $592 · 2024 $369 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
| Alkermes, Inc. | 3 | $61 |
| Lundbeck LLC | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| ABBVIE INC. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: REXULTI, CAPLYTA, UZEDY, COBENFY, VIVITROL, VRAYLAR, ARISTADA, ABILIFY MAINTENA.
Industry payments across WI — which companies pay providers there.
